Ignite Creation Date:
2024-05-05 @ 6:35 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00509470
Status:
COMPLETED
Last Update Posted:
2016-10-18
First Post:
2007-07-28
Brief Title:
Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine
Sponsor:
Tokyo University
Organization:
Tokyo University
Study Overview
Official Title:
ONgoing Evaluation of Depressor Effect And Safety of Combination Therapy With Telmisartan and Low-dose Hydrochlorothiazide in Patients With Hypertension Uncontrolled on Amlodipine Treatment
Status:
COMPLETED
Status Verified Date:
2016-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ONEAST
Brief Summary:
The purpose of this study is to compare depressor effect and safety between combination therapy with telmisartan plus low-dose hydrochlorothiazide and amlodipine in hypertensive patients
Detailed Description:
In hypertensive patients whose blood pressure BP does not reach less than 14090 mmHg with 5mgday of amlodipine are divided the following two groups and BP response laboratory data and adverse effects are compared Group 1 12 week combination therapy with telmisartan plus low-dose hydrochlorothiazide Group 2 Amlodipine is continuously administered
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None